Singapore: Australia based Anteo Diagnostics has decided to acquire DIAsource ImmunoAssays, (DIAsource), a global specia...
Singapore: Australia-based specialty pharmaceutical company, Hatchtech, has been granted a patent by the US Patent and T...
Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key posit...
Singapore: A prominent healthcare industry leader sounded the alarm over Australia's system for approving government fun...
Singapore: Sunshine Heart, a medical devices company listed on Nasdaq and ASX, has appointed that Mr Jon W Salveson to t...
A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New...
Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million i...
Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug deliver...
Singapore: Dr Ben-Zion Weiner, special adviser to the CEO of Teva Pharmaceutical Industries, has been appointed as a non...
Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in ...
Singapore: Elsevier and the Australasian Research Management Society (ARMS) awarded the winners of the 3rd annual Scopu...
Singapore: Merck, a leading company for innovative and top-quality high-tech products in healthcare, lifescience and per...
Singapore: In a bid to launch overseas and to expand its Australian operations, Brisbane-based personalised medicine sta...
Singapore: Scientists at James Cook University (JCU) in Townsville, Queensland, Australia, used sunlight to convert a de...
A doctor by training, Dr Brian A McNamee was enjoying himself in various job roles starting out as product manager, a jo...
Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...
Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth tec...
